$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Global Payments and Sage Launch Embedded Vendor Payments Solution
09:05am, Wednesday, 04'th Jun 2025
ATLANTA--(BUSINESS WIRE)-- #globalpayments--Global Payments announced today that its MineralTree business and Sage launched a vendor payments solution built directly within Sage Intacct.
Treasure Global Launches US$100 Million Digital Asset Treasury Strategy to Power Next-Gen Consumer Intelligence Platform
08:58am, Wednesday, 04'th Jun 2025
Capital Strategy Designed to Strengthen Digital Infrastructure, Enhance Treasury Efficiency, and Accelerate Rollout of Real-Time Data-Driven Retail Platform Capital Strategy Designed to Strengthen Dig
Zeta Global Unveils ‘Zeta Answers,' Ushering in the Next Era of Agentic Marketing
08:30am, Wednesday, 04'th Jun 2025
NEW YORK--(BUSINESS WIRE)--Zeta Global (NYSE: ZETA), the AI marketing cloud, today unveiled ‘Zeta Answers,' an AI-powered intelligence framework that automates complex tasks by turning marketing ins
CHARBONE Hydrogen Executed a USD 50MM Financing to Accelerate its Hydrogen's North American Expansion Facilitated by US Capital Global
08:15am, Wednesday, 04'th Jun 2025
Global private financial group headquartered in San Francisco advises on construction facility to support CHARBONE's expansion of modular green hydrogen facilities in North America. Brossard, Quebec �
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
08:05am, Wednesday, 04'th Jun 2025
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the Goldman Sachs 46th
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology
08:00am, Wednesday, 04'th Jun 2025
Akebia continues to publish important, clinically relevant data to further physicians' understanding of Vafseo® (vadadustat) Akebia continues to publish important, clinically relevant data to further
Global Blue Reports FY24/25 Financial Results in Line With Guidance
07:47am, Wednesday, 04'th Jun 2025
SIGNY, Switzerland--(BUSINESS WIRE)--Global Blue Group Holding AG (NYSE:GB and GB.WS) today announces its financial results for the fourth quarter and twelve-month period ended March 31, 2025. Global
Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
07:00am, Wednesday, 04'th Jun 2025
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respirato
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
07:00am, Wednesday, 04'th Jun 2025
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Confere
UPDATE: RIB Software Launches Global Customer Campaign: “You See It. Together, We'll See It Through”
06:52am, Wednesday, 04'th Jun 2025
New campaign celebrates the people behind engineering and construction and RIB's commitment to delivering digital tools that turn vision into results. New campaign celebrates the people behind enginee
Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
06:45am, Wednesday, 04'th Jun 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference.
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
05:00pm, Tuesday, 03'rd Jun 2025
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for ser
VCI Global Issues 2025 Financial Guidance with Strong Growth Outlook
05:00pm, Tuesday, 03'rd Jun 2025
Targets 41% Revenue Growth, 30% Profit Growth, and a Q3 2025 IPO of Its Capital Markets Subsidiary Targets 41% Revenue Growth, 30% Profit Growth, and a Q3 2025 IPO of Its Capital Markets Subsidiary
Why Venture Global Rocketed Higher Today
04:34pm, Tuesday, 03'rd Jun 2025
Shares of LNG export company Venture Global (VG 21.12%) rallied 18.7% on Tuesday, as of 12:56 p.m. ET.
Establishment Labs to Present at Jefferies Global Healthcare Conference
04:30pm, Tuesday, 03'rd Jun 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Sign In
Buy GTLL